CRISPR gene editing: Can we make cancer cells easier to kill?

Researchers at the Gene Editing Institute have developed a CRISPR gene editing tool to disable genes causing resistance to standard care in cancer patients.

Lung cancer accounts for approximately one in five cancer deaths globally. The high death toll makes the development of new treatments and improvement of old ones a top priority. One of the challenges with traditional chemotherapy is that tumours can develop resistance to treatment. For several years, Eric B Kmiec, PhD, at the Gene Editing Institute of ChristianaCare, USA and […]

Read More… from CRISPR gene editing: Can we make cancer cells easier to kill?

ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity

Research article about the European CanCer Organisation

The European CanCer Organisation (ECCO) is a not-for-profit federation that exists to uphold the right of all European cancer patients to the best possible treatment and care, promoting interaction between all organisations involved in cancer at European level. ECCO aims to raise awareness and improve prevention, diagnosis, treatment and care of cancer patients. CEO of ECCO Birgit Beger spoke with […]

Read More… from ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity